Dr. Kunjahari Medhi

Senior Director Medical Oncology & Hemato-Oncology Medical and Haemato Oncology , Cancer Institute



Trained in Oncology and cancer management from the prestigious AIIMS, New Delhi.

Former Senior Research Associate (SRA) in Medical Oncology in AIIMS, New Delhi under CSIR, HRDG (Govt of India)

Trained on Clinical Research at Oxford University (UK) as INDOX Fellow.

Dr K Medhi is Senior Director Medical Oncology & Hemato-oncology at Medanta, Gurugram. He practices both solid tumor Oncology and Hematolymphoid Oncology in both adults and pediatric patients. His area of expertise is diagnosis and systemic cancer management including all chemotherapy, immunotherapy, targeted therapy,  hormonal therapy, biological therapy etc.

Trained at IIM, Ahmedabad on “Practice management ” under Executive management program. 

Trained at ISB, Hyderabad on “Leadership in Healthcare management “. 

Medical Qualifications

DM (Medical Oncology)All India Institute of Medical Sciences, New Delhi2007
MDS. N. Medical College, Agra (India)2002
MBBS (Gold Medal)Assam Medical College, Dibrugarh (India)1996

Specialization and Expertise

  • Chemotherapy for all cancers
  • Immunotherapy & Targeted chemotherapy
  • All solid cancers and Hematological cancers (Blood cancers- Leukemias, Lymphomas & Myeloma) management.

Memberships & Certifications

  • Lifetime member of ISMPO
  • Lifetime member of AONEI
  • Member of ASCO
  • Trained at IIM, Ahmedabad on "Practice management"
  • Trained at ISB, Hyderabad on "Leadership in Healthcare management "

Awards & Accomplishments

  • "Pratishruti Oncology Consultant Award" in 2022 for the distinguished services in cancer care by Pratishruti Cancer & Palliative Care Trust of ASSAM.
  • "Best Oncologist of the Year" Award in 2020 by "My Brand Better" for excellence in cancer treatment. 
  •  "Oncologist of the Year" Award in 2015 for excellence in cancer treatment by "Brand Achiever".
  • J R Srivastava Gold Medal in Pediatrics for the best Research paper .
  • Gold Medal in MBBS in Assam Medical College (Dibrugarh university)
  • Honours in Biochemistry and obstetrics & Gynecology in MBBS (Dibrugarh University)
  • Blue Star Foundation cash Award for securing highest marks in ENT in Final MBBS (Dibrugarh University)


  • Kunjahari Medhi, Lalit Kumar, Atul Sharma, Vinod Raina, V Kochupillai, R Dawar & E Sreedhar. "Hairy cell leukemia: Experience at a tertiary cancer centre in Northern India. Indian Journal of Medical and Paediatric Oncology 2006; 27(1): 8- 14 :   1,
  • Kunjahari Medhi. "ACVBP versus CHOP plus Radiotherapy for localized aggressive lymphoma”- Selected Summary. Indian Journal of Medical and Paediatric Oncology 2006; 27(1): 27- 29 :   2,
  • Gupta A, Sharma MC, Kochupillai V, Kichendasse G, Atri S, Medhi K. Primary pulmonary rhabdomyosarcoma in adults: case report and review of the literature.Clinical Lung Cancer 2007; 8(6): 389-91. :   3,
  • Vinod Raina, Kunjahari Medhi, Rajive Kumar, Pratibha A Kadam, Satyapal Kataria, Anita Chopra and Dipti Kalita. Burkitt Leukemia after treatment of primary mediastinal nonseminomatous germ-cell tumor. Dignosis in Oncology in Journal of Clinical Oncology 2008; 20(13): 2212-2214. :   4,
  • V. Raina, K. Medhi, S. V. Deo, N. K. Shukla, G. K. Rath. Pattern of relapse in 412 cases of locally advanced breast cancer (LABC) from a single centre in India. Journal of Clinical Oncology 2008;26 (May 20 suppl): abstr 12012 :   5,
  • Kunjahari Medhi, Rajive Kumar, Arvind Rishi, Lalit Kumar, Sameer Bakhshi. Subcutaneous panniculitis like T cell Lymphoma with hemophagocytosis: Complete remission with BFM 90 protocol. Clinical and Laboratory observations in Journal of Pediatric Haematology/Oncology 2008; 30(7): 558-561 :   6,
  • Chandan Jyoti Das, Kunjahari Medhi. Proton MR Spectroscopy of Tubercular Breast Abscess-Report of a case. Journal of Computer Assisted Tomography 2008; 32: 599-601 :   7,
  • Kunjahari Medhi, Dipti Kalita, Anita Chopra, Mona Anand, Vinod Raina and Rajive Kumar. Multiple myeloma presenting with co-existing severe marrow hypoplasia. Indian Journal of Pathology and Microbiology 2008; 51: 543-45 :   8,
  • Majumdar M, Kumar R, Anand M, Kalita D, Ghara N, Chopra A, Medhi K, Sharma A, Kumar L and Raina V. Plasma cell leukemia-a study of 28 cases from India. Hematology2009;14:198-203 :   9,
  • Singhal M, Raina V, Medhi K, Gupta C, Reddy RM. Heart as the site of first relapse in diffuse large B-cell lymphoma. Indian Journal of Cancer 2010;47:220-222 :   10,
  • Muzumder S, Das P, Kumar M, Bhasker S, Sarkar C, Medhi K, Rath GK, Iyer VK. Primary Epithelioid Angiosarcoma of the breast masquerading as carcinoma. Current Oncology 2010; 17: 64-9. :   11,
  • Raina V, Medhi K, Shukla NK, Deo SVS, Sharma A, Mohanty BK, Sharma DN. Outcome of combined modality treatment including neoadjuvant chemotherapy of 128 cases of locally advanced breast cancer: data from tertiary cancer center in Northern India. Original Article in Indian journal of Cancer 2011 Jan-Mar;48(1):80- 5 :   12,
  • Medhi K, Raina V, Kumar L, Sharma A, Bakhshi S, Gupta R and Kumar R. Response Assessment of Patients with Chronic Myeloid Leukemia receiving Imatinib Mesylate (Glivec) Therapy: Experience from a single center in Developing Country. Original Article in Leukemia and Lymphoma 2010 October; 51(10): 1850-1854 :   13,